Panagora Asset Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.8M | Buy |
713,491
+97,239
| +16% | +$4.2M | 0.14% | 143 |
|
|
2025
Q1 | $21.3M | Buy |
616,252
+107,445
| +21% | +$3.71M | 0.11% | 170 |
|
|
2024
Q4 | $14M | Sell |
508,807
-240,012
| -32% | -$6.59M | 0.06% | 203 |
|
|
2024
Q3 | $19.1M | Buy |
748,819
+20,856
| +3% | +$531K | 0.09% | 175 |
|
|
2024
Q2 | $18.4M | Buy |
727,963
+312,686
| +75% | +$7.92M | 0.09% | 165 |
|
|
2024
Q1 | $12.8M | Buy |
415,277
+222,435
| +115% | +$6.88M | 0.07% | 210 |
|
|
2023
Q4 | $7.79M | Buy |
192,842
+16,298
| +9% | +$658K | 0.04% | 259 |
|
|
2023
Q3 | $4.66M | Buy |
176,544
+36,299
| +26% | +$957K | 0.03% | 313 |
|
|
2023
Q2 | $2.41M | Buy |
+140,245
| New | +$2.41M | 0.01% | 492 |
|
|
2021
Q3 | – | Sell |
-4,060
| Closed | -$247K | – | 1766 |
|
|
2021
Q2 | $247K | Buy |
+4,060
| New | +$247K | ﹤0.01% | 1600 |
|